auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
A phase 1 Randomized, Single-Centre, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSV¿-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects
HALPERIN, Scott A × Unknown
3 grants totalling $8.2M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Government of Ontario - Ministry of Health and Long-Term Care | $3.2B | Shared Health Priorities Initiative |
| Government of Ontario - Ministry of Health and Long-Term Care | $3.2B | Shared Health Priorities Initiative |
| Government of Ontario - Ministry of Health and Long-Term Care | $3.2B | Shared Health Priorities Initiative |
| Gouvernement du Québec - Ministère de la Santé et des Services sociaux | $2.5B | Shared Health Priorities Initiative |
| Gouvernement du Québec - Ministère de la santé et des Services sociaux | $2.5B | Shared Health Priorities Initiative |